Klaviyo Co-CEO Unloads Million: Is It a Sell Signal?
Two substantial share sales by Klaviyo's co-CEO in February and March sparked questions about whether this is a warni...
Explore the best Visa credit card with rewards and no annual fee. Enjoy effortless earning on every transaction you make.
9,364 articlesTwo substantial share sales by Klaviyo's co-CEO in February and March sparked questions about whether this is a warni...
Arizona robotics builder FrameTec is expanding its automated framing operation to slash build-cycle times and reduce ...
Gen Z is pushing a rebound in vinyl records and print media, shaping the market while stretching household budgets. T...
A high-yield dividend stock jumped about 31% over three months. As March begins, investors must weigh income potentia...
Social Security COLAs are meant to protect buying power, but there are three essential truths you need to know. This ...
A new, sizable stake in Cal-Maine Foods hints at investor conviction despite a halved income last quarter. This piece...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A rising stake in Instacart highlights how investment groups are pricing the shift to digital grocery. This article e...
A sizable stake emerged as H&R Block faced a meaningful slide. This article breaks down what a block stock down inves...
Long-term investors chase multibagger dreams. This article explores a high-potential biotech setup with 26 late-stage...
HeartBeam heads into 2025 earnings with a mix of potential breakthroughs and headwinds. This guide explains what the ...
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...